EGF and synovial sarcoma: While we demonstrated differential reactivity to interferons and EGF between pSS1 and nSS2 iSGEC cell lines (more prominent for pSS1), we recognize that the SS-related biology of the cells will need to be confirmed in in vivo and ex vivo models for SS.